CRECON Medical Assessment Inc. reveals
the true values
of pharmaceuticals and medical devices
through pharmacoeconomics
(medical economic assessment)
and health technology assessment (HTA).
Pharmacoeconomics (medical economic assessment) and health technology assessment (HTA) provide important evidence
for evaluation
of values and consideration of appropriate prices of pharmaceuticals and medical devices.
CRECON Medical Assessment Inc. (CMA) employs statistical analysis
and high-precision simulation for model construction and cost-effectiveness analysis.
CMA is committed to supporting the development of medical industries including pharmaceuticals
and medical devices by using its expertise.
Pharmacoeconomics (medical economic assessment) and health technology assessment (HTA) provide important evidence for evaluation of values and consideration of appropriate prices of pharmaceuticals and medical devices. The analytical methods and concepts of pharmacoeconomics will become indispensable for the future medical industry.
To evaluate the cost-effectiveness of pharmaceuticals and medical devices by pharmacoeconomics (medical economic assessment), many specialized technologies and knowledge should be combined. We evaluate the cost-effectiveness of medical technologies using advanced modeling and statistical analysis technologies that we have developed over many years.
The socio-economic burden of disease is correlated with the therapeutic value of the disease. However, the estimation of such disease burdens is hardly done. We conduct burden of illness analysis to estimate epidemiological parameters, including the numbers of patients and events, long-term survival rates, and medical expenses.
Real-world data, such as medical and receipt data, and patient outcome data are analyzed based on advanced statistical knowledge and technology.
We support in-house educational and enlightenment activities related to pharmacoeconomics (medical economic assessment) and health technology assessment (HTA), and provide consulting services. Furthermore, we provide consulting services based on review and summarization of technology appraisal (TA) by the UK’s National Institute for Health and Clinical Excellence (NICE).